Want to track MVR0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Medivir AB (MVR0) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.03
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 448.67M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.03
52-Week high 0.16
Beta -
50-Day moving average 0.03
200-Day moving average 0.08
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -10.95%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.36%
Income Statement
Revenue (ttm) 8.5M
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) 5.11%
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -94.4M
Diluted EPS (ttm) -0.66
Quarterly earnings growth (yoy) 57.63%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.66%
Book value per share (mrq) 1.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -94.4M
